Oral contraceptives (OC) have historically been considered a risk factor for gingival diseases. We set out to investigate this premise further, given that, over recent years, hormone concentrations in OC have been substantially reduced. Using a prospective, split-mouth, experimental gingivitis model, pre-menopausal women either taking (n = 14) or not taking (n = 16) OC refrained from all oral hygiene practices in one maxillary (test) quadrant while continuing to perform normal oral hygiene activities in the contralateral (control) quadrant. Mean increases in plaque index (PI), gingival index (GI), and gingival crevicular fluid (GCF) volume from days 0 to 21 were significant in test quadrants (P < 0.05) but did not differ regardless of whether subjects received OC (P > 0.05). PI, GI, and GCF volume did not vary in control quadrants over the course of the study (P > 0.05). Analysis of these data suggests that current OC formulations do not affect the inflammatory response of the gingiva to dental plaque.
Bannemerschult R., Hanker JP, Wunsch C., Fox P., Albring M., Brill K. (1997). A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles. Contraception56:285-290.
2.
Chilton NW, Fleiss JL (1986). Design and analysis of plaque and gingivitis clinical trials. J Clin Periodontol13:400-410.
3.
Ciocca DR, Roig Lmv (1995). Estrogen receptors in human non-target tissues: biological and clinical implications. Endocr Rev16:35-62.
4.
Crook D., Godsland L (1998). Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception57:189-201.
5.
Das AK, Bhowmick S., Dutta A. (1971a). Oral contraceptives and periodontal disease. J Indian Dent Assoc43:47-53.
6.
Das AK, Bhowmick S., Dutta A. (1971b). Oral contraceptives and periodontal disease. Prevalence and severity. J Indian Dent Assoc43:155-158.
7.
El-Ashiry GM, El-Kafrawy AH, Nasr MF, Younis N. (1970). Comparative study of the influence of pregnancy and oral contraceptives on the gingivae. Oral Surg Oral Med Oral Pathol30:472-475.
8.
El-Ashiry GM, El-Kafrawy AH, Nasr MF, Younis N. (1971). Effects of oral contraceptives on the gingiva . J Periodontol42:273-275.
9.
European Community Directive (1991). 91/507/EEC. Brussels, 19 July
10.
Hugoson A. (1971). Gingivitis in pregnant women. A longitudinal clinical study. Odontol Revy22:65-84.
11.
Hujoel PP, Moulton LH (1988). Evaluation of test statistics in split-mouth clinical trials. J Periodontal Res23:378-380.
12.
Kaufman AY (1969). An oral contraceptive as an etiologic factor in producing hyperplastic gingivitis and a neoplasm of the pregnancy tumour type . Oral Surg Oral Med Oral Pathol28:666-670.
13.
Knight GM, Wade BA ( 1974). The effects of hormonal contraceptives on the human periodontium . J Periodontal Res9:18-22.
14.
Lindhe J., Attstrom R. (1967). Gingival exudation during the menstrual cycle . J Periodontal Res2:194-198.
15.
Lindhe J., Bjöm A.-L (1967). Influence of hormonal contraceptives on the gingiva of women. J Periodontal Res2:1-6.
16.
Loe H. (1971). Human research model for the production and prevention of gingivitis. J Dent Res50:256-264.
17.
Loe H., Holm-Pedersen P. (1965). Absence and presence of fluid from normal and inflamed gingivae. Periodontics3:171-177.
18.
Loe H., Silness J. (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand21 :533-551.
19.
Loe H., Theilade E., Jensen SB (1965). Experimental gingivitis in man. J Periodontol36:177-187.
20.
Lynn BD ( 1967). "The pill" as an etiologic agent in hypertrophic gingivitis . Oral Surg Oral Med Oral Pathol24:333-334.
21.
Mariotti A. (1994). Sex steroid hormones and cell dynamics in the periodontium. Crit Rev Oral Biol Med5:27-53.
22.
Offenbacher S., Odle BM, Gray RC, van Dyke TE (1984). Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients . J Periodontal Res19:1-13.
23.
Pankhurst CL, Waite IM, Hicks KA, Allen Y., Harkness RD (1981). The influence of oral contraceptive therapy on the periodontium-duration of drug therapy. J Periodontol52:617-620.
24.
Perry DA (1981). Oral contraceptives and periodontal health. J Western Soc Periodontol29:72-80.
25.
Preshaw PM, Kelly PJ, Heasman PA (1996). Quadratic calibration curves for the Periotron 6000. J Periodontal Res31 :441-443.
26.
Putt MS, Van der Weijden GA, Kleber CJ, Saxton CA (1993). Validation of a 21-day, partial-mouth gingivitis model for evaluating chemotherapeutic dentifrices. J Periodontal Res28:301-307.
27.
Raber-Durlacher JE, van Steenbergen Tjm, van der Velden U., de Graaff J., Abraham-Inpijn L. (1994). Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological and microbiological aspects. J Clin Periodontol21:549-558.
28.
Sherif K. (1999). Benefits and risks of oral contraceptives. Am J Obstet Gynecol180:S343-348.
29.
Silness J., Loe H. (1964). Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand22:121-135.
Sutcliffe PA (1972). Longitudinal study of gingivitis and puberty. J Periodontal Res7:52-58.
32.
Tilakaratne A., Soory M., Ranasinghe SM, Corea Smx, Ekanayake SL, de Silva M. (2000). Effects of hormonal contraceptives on the periodontium, in a population of rural Sri-Lankan women. J Clin Periodontol27:753-757.
33.
Williams CL, Stancel GM (1996). Estrogens and progestins. In: Goodman & Gilman's The Pharmacological basis of therapeutics. Hardman JG, Limbird LE, editors. New York: McGraw-Hill, pp. 1411-1441.
